Claude

What's Next

Current Price

$57.58

Probability-Weighted Value

$163

Asymmetry Ratio

1.83

**Conditional Buy at $57.58.** Probability-weighted value of $163 implies 183% upside. The upside/downside asymmetry is 1.8x, driven by a business growing revenue 22%+ and generating $1.28 billion in FCF while trading at 2.6x EV/Sales -- the cheapest in its peer group and the cheapest in its own history. The condition: the April 30 Q3 FY2026 earnings must confirm growth acceleration and margin expansion from the March layoff. Size to survive being wrong.

Catalyst Calendar

April 30 – Q3 FY2026 Earnings. This is the binary event. Management guided $1.69 billion in revenue (26% YoY growth, accelerating from 23% in Q2). The market needs three things confirmed: (1) Cloud revenue growth holding above 25%, (2) visible margin expansion from the 1,600-person layoff, and (3) Rovo AI adoption metrics beyond the 5 million MAU headline. Atlassian has beaten adjusted EPS in 7 consecutive quarters, including a 67% beat in Q2 FY2026 ($1.22 vs. $0.73 estimate). Another significant beat at these depressed levels, with the RSI at 26 and 6.2% short interest, creates conditions for a violent re-rating.

May-June – Layoff Savings Materialize. The 10% workforce reduction (1,600 employees) will generate $225-236 million in annual savings. The first clean quarter reflecting these savings is Q4 FY2026. This is when GAAP profitability – a milestone Atlassian has never achieved as a public company – becomes plausible. That crossover unlocks index inclusion discussions and opens the stock to value-oriented institutional buyers excluded by GAAP-profitability mandates.

Buyback Execution. The $2.5 billion authorization from October 2025 could retire 16% of the float at current prices. If management is not buying aggressively at $58 after authorizing $2.5 billion, the alignment signal weakens. The next 10-Q will reveal actual execution – watch this closely.

Rovo AI Monetization. Currently bundled free with Premium/Enterprise tiers. Projected to contribute $400-600 million in Cloud ARR by calendar 2027. By late 2026, the market demands evidence of measurable ARPU uplift, not just user counts.

No Results

**What the market watches most closely:** Whether AI disruption panic is justified. The stock has fallen 57% in 2026 alone. Every earnings beat that contradicts the "AI kills Jira" narrative chips away at the bear case. The lowest analyst target ($120) is still 108% above the current price.

LEAPS / Options

Options on TEAM are liquid and present an actionable setup. Implied volatility of 70-80% is elevated but reflects genuine uncertainty. Two LEAPS cycles are available: June 2027 (14 months) and January 2028 (21 months).

Market Context

Avg Implied Vol

72%

RSI (14-day)

26.1

Short % Float

6.2%

Days to Cover

1.4

Top LEAPS Contracts

The January 2028 cycle is preferred – it offers better liquidity and 21 months for the thesis to play out, capturing both FY2026 and FY2027 earnings.

No Results

Payoff by Scenario

Bull case ($250): Jan 2028 $100C returns 10.5x. Jan 2028 $70C returns 7.5x. Every contract is deeply profitable.

Base case ($150): All contracts are profitable. Jan 2028 $60C returns 2.7x. Jan 2028 $90C returns 2.9x. Even moderate re-rating nearly triples the investment.

Bear case ($35): All contracts expire worthless. Maximum loss is the premium paid – a critical advantage over stock ownership, which has $57.58 of downside.

Probability-Weighted Expected Value

No Results

Every contract has a positive probability-weighted expected return. The $100C offers the highest expected return multiple (1.86x) but carries the highest probability of total loss. The $70C balances liquidity (284 OI), leverage (7.5x bull), and expected return (1.11x).

Options Verdict

**Preferred trade: Jan 2028 $70 Call at $21.30.** Best balance of liquidity (284 OI, 28 daily volume), leverage (7.5x bull return), and probability-weighted return (1.11x). Breakeven of $91.30 is 59% above current but well below every analyst target ($120 minimum). Theta decay of $0.019/day ($0.57/month) is manageable over 21 months. Maximum loss: $2,130 per contract.

Lower risk alternative: Jan 2028 $60 Call at $24.60. Deeper in the money (delta 0.72), lower breakeven at $84.60 (47% above current). Less leverage but higher probability of profit.

Higher conviction alternative: Jan 2028 $100 Call at $13.10. Highest open interest (643), tightest spreads, best expected return multiple (1.86x). Requires the stock to nearly double to break even. Only appropriate for high-conviction positions.

Avoid: June 2027 calls expire before FY2027 earnings, which should capture AI monetization and the full effect of layoff-driven margin expansion. The extra 7 months of the January 2028 cycle is worth the premium.

**Size constraint: 1-2% of portfolio maximum in LEAPS.** IV at 70-80% means you are paying a large time-value premium. If IV compresses after earnings (even with a beat), LEAPS values could decline despite the stock rising. Wide bid-ask spreads on most strikes mean execution costs are real. Use limit orders. The 25% probability of total loss is not a rounding error -- it is the price of asymmetry.